Daclizumab therapy in kidney transplantation - Different mechanisms of action in- versus ex-vivo?

Transplant Immunology

Volumn 14, Issue 1, 2005, Pages 43-47

  Forrest, Kathy ^a   Logan, Barbara ^b   Strange, Jennifer ^c   Roszman, Thomas L ^c   Goebel, Jens ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

CD25; Daclizumab; Interleukin 2; Signal transduction; Transplantation

Indexed keywords

AZATHIOPRINE; DACLIZUMAB; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHYTOHEMAGGLUTININ; STEROID; TACROLIMUS; TYROSINE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FLOW CYTOMETRY; HUMAN; IMMUNOBLOTTING; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; UPREGULATION;

EID: 16244371743     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.12.001     Document Type: Article

References (21)

1. F. Vincenti, R. Kirkman, S. Light, G. Bumgardner, M. Pescovitz, and P. Halloran Interleukin-2-receptor blockade with daclizumab to prevent acute ejection in renal transplantation N. Engl. J. Med. 338 3 1998 161 165
2. AC Webster, EG Playford, G Higgins, JR Chapman, and JC Craig Interleukin-2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials Transplantation 77 2 2004 66 76
3. C.C. Baan, I.C. van Riemsdijk-Overbeeke, M.J.A.M. Boelars-van Haperen, J.M.N. Ijzermans, and W. Weimar Inhibition of the IL-15 pathway in anti-CD25 mAb treated renal allograft recipients Transpl. Immunol. 10 2002 81 87
4. J. Tkaczuk, C.-L. Yu, S. Bakash, E.L. Milford, C.B. Carpenter, and S.J. Burakoff Effect of Anti-IL-2R α antibody on IL-2-induced Jak/STAT signaling Am. J. Transpl. 2 2002 31 40
5. B.H. Nelson, and DM. Willerford Biology of the interleukin-2 receptor Adv. Immunol. 70 1998 1 81
6. J. Goebel, E. Stevens, K. Forrest, and T.L. Roszman Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events Transpl. Immunol. 8 2000 153 159
7. C.M. Bacon, D.W. McVicar, J.R. Ortaldo, R.C. Rees, J.J. O'Shea, and JA. Johnston Interleukin-12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12 J. Exp. Med. 181 1 1995 399 404
8. J.-X. Lin, and W.J. Leonard Signaling from the IL-2 receptor to the nucleus Cytokine Growth Factor Rev. 8 4 1997 313 332
9. J. Goebel, A. Franks, F. Robey, J. Mikovits, and R.P. Lowry Attenuation of IL-2 receptor signaling by CD4-ligation requires polymerized cytoskeletal actin but not p56lck Transpl. Proc. 31 1-2 1999 822 824
10. C.J. Kelly T cell function in chronic renal failure and dialysis Blood Purif. 12 1994 36 41
11. G. Beaurain, C. Naret, L. Marcon, G. Grateau, T. Drueke, and P. Urena In-vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients Kidney Int. 36 1989 636 644
12. D. Modai, S. Berman, Y. Sheleg, M. Cohn, J. Weissgarten, and Z. Averbukh Interleukin-2 receptor is similarly expressed by activated lymphocytes from patients on chronic hemodialysis and healthy subjects Clin. Immunol. Immunopathol. 55 2 1990 237 241
13. I.C. Van Riemsdijk-van Overbeeke, C.C. Baan, C.J. Knoop, E.H.M. Loonen, R. Zietse, and W. Weimar Quantitative flow cytometry shows activation of the TNF-α system but not of the IL-2 system at the single cell level in renal replacement therapy Nephrol. Dial. Transplant. 16 2001 1430 1435
14. I.C. Van Riemsdijk, C.C. Baan, E.H.M. Loonen, C.J. Knoop, G.N. Betonico, and H.G.M. Niesters T cells activate the tumor necrosis factor-α system during hemodialysis, resulting in tachyphylaxis Kidney Int. 59 2001 883 892
15. F. Vincenti, M. Lantz, J. Birnbaum, M. Garovoy, D. Mould, and J. Hakimi A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation Transplantation 63 1 1997 33 38
16. W.A. Briggs, Z.-H. Gao, J.-J. Xing, P.J. Scheel, L.F. Gimenez, and M.D. Samaniego Suppression of dialysis patients' lymphocyte il-2r expression by glucocorticoids and cyclosporine Cytokine 9 8 1997 624 628
17. J.C. Morris, and T.A. Waldmann Advances in interleukin-2 receptor targeted treatment Ann. Rheum. Dis. 59 suppl. I 2000 i109 i114
18. P.L. Amlot, E. Rawlings, O.N. Fernando, P.J. Griffin, G. Heinrich, and M.H. Schreier Prolonged action of a chimeric interleukin-2 receptor (cd25) monoclonal antibody used in cadaveric renal transplantation Transplantation 60 7 1995 748 756
19. A.M. Savo, B.K. Book, S. Henson, J. Hakimi, and M.D. Pescovitz Daclizumab rapidly saturates interleukin-2 receptor-α (CD25) on lymph node lymphocytes in children Transpl. Proc. 31 1-2 1999 1182 1183
20. A. Krensky, A. Weiss, G. Crabtree, M.M. Davis, and P. Parham T-lymphocyte-antigen interactions in transplant ejection N. Engl. J. Med. 322 8 1990 510 517
21. J.F. McDyer, Z. Li, S. John, X. Yu, C. Wu, and J.A. Ragheb IL-2 receptor blockade inhibits late, but not early, IFN-γ and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-γ production J. Immunol. 169 2002 2736 2746